Brentuximab vedotin with chemotherapy for patients with previously untreated, stage III/IV classical hodgkin lymphoma: 5-year update of the ECHELON-1 study Meeting Abstract
| Authors: | Straus, D. J.; Dlugosz-Danecka, M.; Connors, J. M.; Illés, A.; Picardi, M.; Lech-Marańda, E.; Feldman, T.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; Walewski, J.; Ramchandren, R.; Zinzani, P. L.; Hutchings, M.; Munoz, J.; Kim, W. S.; Advani, R.; Ansell, S. M.; Younes, A.; Gallamini, A.; Liu, R.; Little, M.; Fenton, K.; Fanale, M. A.; Radford, J. A. |
| Abstract Title: | Brentuximab vedotin with chemotherapy for patients with previously untreated, stage III/IV classical hodgkin lymphoma: 5-year update of the ECHELON-1 study |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205605195 |
| DOI: | 10.1182/blood-2020-137089 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 26 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
